| Pharmaceutical active ingredients: |
| Entecavir |
| Available forms, composition and doses of Baraclude: |
| Solution; Oral; Entecavir 0.05 mg / mlTablets, Film-Coated; Oral; Entecavir 0.5 mgTablets, Film-Coated; Oral; Entecavir 1 mgTablets; Oral; Entecavir 0.5 mgTablets; Oral; Entecavir 1 mg |
| Baraclude medical category: |
| Human:Nucleosides and nucleotides |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AF10 - Entecavir |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbDKSHInvidaTaisho PharmaceuticalZuellig Pharma |
| Related documents and information about Baraclude: |
| Baraclude prescribing information (PDF) |